Methadone Clinics in Hawaii

Methadone clinics in Hawaii help reduce the costly problem of opiate addiction. They provide effective medically assisted treatment for opiate dependence that helps restore stability to lives of those addicted to opioids.

Methadone Clinics in cities of Hawaii

Opioid Use Disorder Treatment Across Hawaii’s Islands

Getting into medication treatment for opioid use disorder (OUD) in Hawaii means working with the state’s geography. Opioid treatment programs and office-based prescribers cluster on Oahu, while people on Maui, Kauai, and Hawaii Island often live far from the nearest clinic, and inter-island travel for a daily dose is not realistic.

That gap is where telehealth and take-home dosing matter most. Hawaii offers all three FDA-approved medications: methadone, buprenorphine (including Suboxone), and naltrexone (Vivitrol), through both opioid treatment programs (OTPs) and office-based care.

The listings on this page show programs by island and city. Helpline staff can talk through options if you are not sure where to start.

Where and How to Access Medications

Three medications are FDA-approved for the treatment of opioid use disorder, and they are dispensed in different settings. Understanding that difference tells you what the listings on this page actually represent.

Methadone is a full opioid agonist that steadies withdrawal and cravings.

For OUD, it is dispensed only through a federally certified opioid treatment program, not a regular pharmacy. This is why methadone care in Hawaii runs through OTPs on Oahu and a limited number of neighbor-island sites. Dosing starts daily and moves toward take-home doses as a person stabilizes.

Buprenorphine, including Suboxone and other buprenorphine-naloxone films and tablets, is a partial agonist with a ceiling effect that lowers overdose risk.

Since the federal X-waiver ended in 2023, any clinician with a standard DEA registration can prescribe it in an office-based setting (office-based opioid treatment, or OBOT), and you fill it at a pharmacy. Extended-release injectable buprenorphine, such as Sublocade, is a monthly shot. Buprenorphine is also offered inside OTPs.

To see how the two agonists compare, this overview of how methadone and Suboxone differ in daily life lays out the trade-offs.

Naltrexone, including the monthly Vivitrol injection, blocks opioid effects and is not a controlled substance.

Any licensed prescriber can order naltrexone. However, treatment can only begin after a person has been off opioids for a set period, which a clinician will time to avoid withdrawal.

Which medication fits is a decision to make with a provider. Each works, and the right choice depends on your health, your history, and your life. The way an opioid treatment program is structured is worth understanding before you call.

State Rules, Medicaid, and Naloxone Access in Hawaii

Hawaii’s Medicaid program, Med-QUEST, covers all three medications for opioid use disorder, delivered through five managed care health plans. Because plans differ in networks and cost-sharing, it helps to confirm which providers and pharmacies your specific plan works with before your first visit. Private insurance and Medicare also cover MOUD, and some programs offer sliding-scale self-pay.

The state’s opioid treatment programs are certified and monitored by the Hawaii Department of Health’s Alcohol and Drug Abuse Division (ADAD), alongside federal SAMHSA certification.

Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment), allowed treatment to start by telehealth, and removed older barriers to admission. Take-home eligibility is decided by your program based on stability. As of 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit.

These flexibilities run through 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD stays OTP-dispensed.

Keeping to a consistent methadone dose over time is part of what makes the medication work.

Naloxone, the medication that reverses an opioid overdose, is available in Hawaii over the counter, through a pharmacy standing order, and free from community programs. The Hawaii Health and Harm Reduction Center (HHHRC) mails naloxone at no cost to residents of Oahu, Kauai, Maui, and Hawaii Island and stocks naloxone vending machines on Oahu.

In an overdose situation, Hawaiians don’t have to hesitate to call 911. Hawaii’s Good Samaritan law protects people who call for help during an overdose from certain drug-possession charges.

And if you’re wondering how treatment can affect employment, workplace privacy questions are common. Here is what employers can and cannot ask about methadone treatment.

Hawaii’s Overdose Picture and What It Means for Treatment

Hawaii’s overdose situation is not the fentanyl-only story seen on much of the mainland. According to the state’s Hawaii Overdose Initiative, drawing on CDC SUDORS data, unintentional drug overdose deaths in Hawaii rose from 252 in 2021 to 360 in 2024. Methamphetamine drives most of that loss, involved in more than 75 percent of deaths, and meth-involved deaths jumped from 214 in 2023 to 275 in 2024.

Deaths involving illicitly made fentanyl alone actually fell, from 43 in 2023 to 28 in 2024, which the initiative attributes partly to wider naloxone and fentanyl-test-strip access. The practical takeaway is that fentanyl increasingly turns up mixed with stimulants, so an unexpected opioid can be present even when someone believes they are using only meth.

That is one reason carrying naloxone matters here, and one reason effective medication treatment for opioid use disorder is worth starting. For context on the condition itself, this background on opioid addiction is a useful starting point.

How to Start Treatment and Find a Program Near You

Starting begins with an intake assessment, where a clinician reviews your history, discusses which medication fits, and explains what the first days look like. If you have been using fentanyl, tell the clinic, because starting buprenorphine too soon after fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so the clinician times your first dose carefully.

Some Hawaii programs offer same-day or next-day starts, and buprenorphine can often begin by telehealth, which is the fastest route for someone on a neighbor island without a nearby clinic. Bring an ID and insurance information if you have them, but not having them should not stop you from calling.

Use the island and city listings on this page, or the helpline, to reach a program. If a residential or hospital-based level of care is being considered, this explains how inpatient opioid treatment differs from outpatient care. Broader guidance on opioid use disorder treatment options can help you prepare for that first call.

Pregnancy, Native Hawaiian Communities, and Reentry

Some situations in Hawaii call for extra planning.

For pregnant patients, medication treatment with methadone or buprenorphine is the recommended standard of care. Stopping suddenly carries real risk, and staying in treatment is protective for both parent and baby.

Neonatal opioid withdrawal syndrome (NOWS) is manageable and expected, and Hawaii uses a Plan of Safe Care to coordinate support rather than punishment. Fear of child-welfare involvement keeps some pregnant patients from seeking care, so it is worth knowing that treatment is what clinicians and public-health guidance recommend.

You can read more here about methadone treatment during pregnancy.

Native Hawaiian and other Pacific Islander communities have carried a disproportionate share of the state’s overdose increase, making culturally grounded, accessible treatment a specific priority.

For people leaving jail or entering treatment through the courts, continuity of medication matters most in the first weeks after release, when overdose risk is highest.

Families wanting to support a loved one through any of these situations can find direction in this guide for helping a loved one in treatment.

FAQ about MOUD in Hawaii

Does Med-QUEST cover methadone and Suboxone?

Yes. Hawaii’s Medicaid program, Med-QUEST, covers all three FDA-approved medications for opioid use disorder, including methadone, buprenorphine and Suboxone, and naltrexone. Coverage runs through five managed care plans, so confirm that your chosen provider and pharmacy are in your plan’s network.

Can I start Suboxone by telehealth if I live on a neighbor island?

Often, yes. As of 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit. This is frequently the fastest option when the nearest clinic is on another island. Telehealth rules run through 2026 and are still being finalized, so confirm what is current with a provider.

Do I have to go in every day for methadone?

At first, usually yes. Methadone for opioid use disorder is dispensed through an opioid treatment program, and dosing starts daily. As a person becomes stable, federal rules updated in 2024 allow take-home supplies of up to 28 days, with eligibility decided by the program.

Is medication treatment just trading one drug for another?

No. This is a common myth. Methadone and buprenorphine are prescribed, steady doses that prevent withdrawal and cravings without the cycle of intoxication, which allows people to work, parent, and live stably. Major health authorities, including SAMHSA and NIDA, consider medication the standard of care for opioid use disorder. You can explore more answers to common treatment questions.

What if I’ve been in treatment before and want to restart?

Returning to treatment is common and encouraged, and a return to use is treated as a manageable part of a chronic condition, not a failure. A program can restart your medication and, where appropriate, help arrange take-home or telehealth options that fit your schedule and island location.

Sources and Disclosures

Last reviewed July 2026.

Sources:

Hawaii Overdose Initiative, Office of Wellness and Resilience, drawing on CDC State Unintentional Drug Overdose Reporting System (SUDORS) data, 2026. https://osp.hawaii.gov/hoi/
Hawaii Department of Health, Alcohol and Drug Abuse Division (ADAD) and Harm Reduction Services Branch, 2026. https://health.hawaii.gov/substance-abuse/
Hawaii Med-QUEST Division, Medicaid coverage of behavioral health and MOUD, 2026. https://medquest.hawaii.gov/en/members-applicants/quest-integration-coverage/medical-benefits.html
Hawaii Health and Harm Reduction Center (HHHRC), naloxone access, 2026. https://www.hhhrc.org/naloxone
Substance Abuse and Mental Health Services Administration (SAMHSA), MOUD and 42 CFR Part 8 (2024), 2026. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8
Drug Enforcement Administration (DEA) and HHS, telemedicine prescribing flexibilities effective through December 31, 2026. https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care
U.S. Food and Drug Administration (FDA), approved medications for opioid use disorder. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/information-about-medications-opioid-use-disorder-moud

MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com is not owned or operated by any treatment facility and does not endorse any treatment facility or guarantee the quality of care provided.

Calls to any general helpline may be answered or returned by a paid advertiser. By calling the helpline you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.

Call For Help With Addiction

Talk To Someone Now